scispace - formally typeset
Search or ask a question

What is the scientific consensus on adhd? 


Best insight from top research papers

The scientific consensus on ADHD, particularly in adolescents and adults with comorbid substance use disorder (SUD), emphasizes the importance of routine screening, integrated treatment approaches, and the use of long-acting stimulants as first-line pharmacotherapy . Consensus statements highlight the need for early recognition of ADHD in individuals with SUD, prompt initiation of diagnostic procedures, and the preference for combined pharmacological and psychosocial treatments . Additionally, involving patients and families in the management program, addressing coexisting conditions alongside ADHD, and implementing behavioral, medication, and educational interventions are crucial aspects of managing ADHD effectively . The consensus underscores the significance of a multidisciplinary approach tailored to the specific needs of each patient to achieve optimal outcomes in ADHD management.

Answers from top 5 papers

More filters
Papers (5)Insight
The scientific consensus recommends routine screening, prompt diagnosis, and integrated treatment with medication and psychotherapy, including higher-dose long-acting stimulants, for adults with substance use disorder and ADHD.
The scientific consensus on ADHD management includes a multidisciplinary approach involving education, family involvement, target outcomes, and treatment modalities like behavioral interventions, medications, and educational interventions.
A panel of ADHD experts reached a high level of consensus on key criteria and therapeutic guidelines, providing valuable insights for clinical practice in managing ADHD.
The scientific consensus recommends routine screening for ADHD in adolescents with substance use disorder, long-acting stimulants as first-line treatment, and integrating pharmacotherapy with psychosocial interventions.
The scientific consensus recommends routine screening for ADHD in adolescents with substance use disorder, long-acting stimulants as first-line treatment, and integrating pharmacotherapy with psychosocial interventions.

Related Questions

What are research gaps about ADHD?5 answersResearch gaps about ADHD include methodological issues and gaps in the current evidence, such as potential bias, lack of high-quality data comparing different treatments, and problems with observational studies. There is a need for accurate, brief standardized diagnosis and assessment, as well as comparative effectiveness and safety studies for pharmacologic treatments in children under 6 years of age. Long-term treatment effectiveness and variability in prevalence, diagnosis, and treatment are also areas that require further research. Additionally, there is a need for case identification and measurement of prevalence and outcomes, comparative effectiveness studies for psychosocial and pharmacologic treatments, and identification of person-level effect modifiers. Future research should focus on addressing these gaps to improve decision-making about treatment for ADHD.
What is the current science on adhd in women over 40?4 answersADHD in women over 40 is an area that has received limited research attention. However, recent studies suggest that ADHD can persist into older adulthood. One qualitative study found that women over the age of 60 who were diagnosed with ADHD reported experiencing peer rejection, feeling different, and difficulties in work and relationships. However, they also described finding creative solutions to their attention problems and reported that diagnosis and treatment assisted with self-acceptance and appreciation of their strengths. Another study compared adult women with ADHD and bipolar disorder (BD) and found that self-report measures of ADHD symptoms best discriminated between the two conditions. ADHD interview measures and self-ratings of ADHD symptoms were more effective in distinguishing ADHD from BD in adult women. Overall, more research is needed to better understand ADHD in women over 40 and to develop appropriate diagnostic and treatment approaches.
What are the latest findings on ADHD?5 answersRecent findings on ADHD include: 1. Children with ADHD have a genuine impairment in processing visual stimuli, indicating a potential cognitive deficit. This challenges the idea that ADHD represents a stable nosographic entity.2. Genome-wide association studies (GWAS) have identified candidate genes and biological pathways associated with ADHD, such as AHI1, ALG2, DNM1, Reactome SEMA4D, and Reactome NCAM1 interactions. These findings provide insights into the complex genetic mechanism of ADHD.3. Neuroimaging research on ADHD has identified statistically robust differences in structural brain indices in children with ADHD compared to typically developing controls. However, functional and resting-state functional studies have presented conflicting results. Large-scale, multimodal, and open-science initiatives are being pursued to unravel the neurobiology of ADHD.4. Neuroimaging studies in children/adolescents with ADHD have shown divergent findings, possibly due to heterogeneous clinical populations and various experimental designs. Regional convergence is lacking, suggesting that ADHD pathophysiology might involve network interactions rather than just regional abnormality. Further high-powered investigations are needed.5. Genetic studies have revealed strong genetic overlaps between ADHD and Autism Spectrum Disorder, as well as Intellectual Disability. ADHD also shows genetic correlations with other neuropsychiatric disorders and non-psychiatric characteristics. These findings highlight the neurodevelopmental nature of ADHD and the need for a developmental perspective in genetic studies.
What are the most important and significant papers on ADHD in the last 10 years?5 answersThe literature on ADHD in the last 10 years has provided important insights. Research has shown that exposure to maltreatment is a risk factor for ADHD symptoms later in development, although findings are not consistent. The Italian Lombardy ADHD Register has provided valuable data on diagnostic assessment, therapeutic approaches, and follow-up of patients with ADHD. External factors such as premature birth, low birth weight, maternal smoking, alcohol consumption, and psychological disorders during pregnancy have been linked to the development of ADHD. A genome-wide association meta-analysis has identified 12 independent loci associated with ADHD, shedding light on the underlying biology of the disorder. The increasing number of publications on ADHD highlights the need for comprehensive reviews to stay updated on the literature.
What is known about adhd in children?5 answersADHD is a prevalent neurodevelopmental disorder in children, characterized by attention difficulties, hyperactivity, and impulsivity. It can have negative impacts on social, emotional, behavioral, and academic domains. ADHD typically appears in early childhood and can make it challenging for children to control their responses and follow instructions. The evaluation for ADHD involves a comprehensive assessment, including a history and physical examination, to rule out other conditions that may mimic ADHD. Psychosocial interventions are recommended as the first-line treatment for preschool children, while stimulant medications are effective for reducing symptoms in elementary school children and adolescents. Regular follow-up is crucial for monitoring symptoms, function, and medication use. Electrophysiological studies have shown differences in brain activity between ADHD children and controls, particularly in error-related potentials, suggesting potential diagnostic applications. Effective teaching strategies and assessment tools can help ADHD children develop their multiple intelligences and achieve academic success.
What are some of the research gaps in ADHD?5 answersThere are several research gaps in ADHD. Firstly, there is a need for more studies on biomarkers, course and follow-up, and non-pharmacological interventions, particularly in India. Secondly, there is a lack of comprehensive, multi-modal treatments for children and adolescents with ADHD, with concerns about the adequacy of the assessment process and the minimal integration of disciplines. Thirdly, there is an underdiagnosis and undertreatment of ADHD in adults worldwide, leading to major societal and personal costs. Additionally, there is a need for larger sample sizes, prospective research designs, and studies with matched controls in order to strengthen the evidence base. These research gaps highlight the need for further investigation and development of effective interventions and diagnostic tools for ADHD.